• SmartestCrowd
    • No organizations
    • No projects
0
0
Praxis Precision Medicines Announces Topline Results from the Essential1 Study of Ulixacaltamide for the Treatment of Essential Tremor and Continued Advancement of Program to Phase 3 - Yahoo Finance
3/3/23 at 12:30pm
Organization
Yahoo Entertainment
Authors
Praxis Precision Medicines Inc.
55 words
0
Comments
Based upon observed efficacy and safety profile, Praxis intends to engage with the FDA in an end of Phase 2 meeting and initiate a ulixacaltamide Phase 3...
You are the first to view
https://finance.yahoo.com/news/praxis-precision-medicines-announces-topline-123000869.html
Create an account or login to join the discussion